Cagent Vascular
Health & Medical Electronics
$65.7Mtotal raised · 5 rounds on record
$24.5Mlatest round · Venture round · May 2026 · 5 mo ago
1backers · USVP
68team · US Form 5500 (plan participants) · Dec 2025 · +33% in a year
Overview
Cagent Vascular pioneers Serration Remodeling Therapy (SRT) creating controlled lines of weakness to release the internal elastic lamina, reducing recoil and increasing luminal gain in PAD angioplasty.
Funding and backers
Total raised
$65.7M
5 rounds on record
Latest round
$24.5M
Venture round · May 2026 · 5 mo ago
Team
68
US Form 5500 (plan participants) · Dec 2025 · +33% in a year
Backers
1
USVP
The money's age
Fresh money
5 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
May 18
Raised a round Venture round $24.5M · SEC Form D
2025
Team of 68 was 51 · US Form 5500 (plan participants)
Jan 30, 2024
Raised a round Venture round $28.7M · SEC Form D
Apr 21, 2023
Took on debt financing $7.2M · SEC Form D
Jun 15, 2021
Raised a round Venture round $9.5M · SEC Form D
Jul 11, 2017
Raised a round Venture round $3M · SEC Form D
2014
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | May 2026 | $24.5M | — | SEC Form D |
| Venture round | Jan 2024 | $28.7M | — | SEC Form D |
| Debt Financing | Apr 2023 | $7.2M | — | SEC Form D |
| Venture round | Jun 2021 | $9.5M | — | SEC Form D |
| Venture round | Jul 2017 | $3M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Cagent Vascular, LLC | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Carol BurnsExecutive Officer, DirectorSEC Form D
Dennis McGrathExecutive OfficerSEC Form D
Brian WalshExecutive Officer, DirectorSEC Form D
Aaron GreenExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
backs Charco Neurotech
Similar startupsby what they do, their industry and backers
Who We Are Giving patients the ability to gain power over pain About Neuros There are nearly two million amputees in the U.S., with 185,000…
AirVault™ is a medical device developed by Gasgon Medical (Ireland), intended to remove Air-in-Line bubbles from intravenous (IV) infusion…
Cincinnati-based surgical procedure company focused on innovative development, commercialization of medical devices for treatment of…
The CUE1 and CUE1+ by Charco Neurotech offers a novel, non-invasive approach to increasing quality of life for people with Parkinson's.
Sequana Medical is a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer.
Luminopia is the first FDA-cleared binocular therapy for amblyopia.
Financials
Total raised
$73M
Latest round
Venture - Series Unknown
Funding rounds
5
People
Carol Burns
Executive Officer, Director
Dennis McGrath
Executive Officer
Brian Walsh
Executive Officer, Director
Aaron Green
Executive Officer
Peter Schneider
Director
Robert Giasolli
Director
Fred Lampropoulos
Director
Mike Markert
Director
Marc-Andre Marcotte
Director
Greg Fredde
Director
Casey Tansey
Director
Bruce Blumfield
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
USVPVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Wayne
United States
HQ
10-50 est. staff